B6.Cg-Cd3etm1Mal Prss16tm1.1Mal/Cnbc

Status

Available to order

EMMA IDEM:08270
Citation informationRRID:IMSR_EM:08270 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.Cg-Cd3etm1Mal Prss16tm1.1Mal/Cnbc
Alternative nameTSSP KO CD3E KO
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolCd3etm1Mal, Prss16tm1.1Mal
Gene/Transgene symbolCd3e, Prss16

Information from provider

ProviderAlice Carrier
Provider affiliationStress Cell, CRCM
Additional ownerDr. Marie Malissen, Centre d'Immunologie de Marseille-Luminy (CIML), France
Genetic informationDeletion of Prss16 gene encoding thymus-specific serine protease (TSSP), on a CD3epsilon-deficient background.
Phenotypic informationHomozygous:
Partial immunodeficiency (altered repertoire of CD4 T cells).

Heterozygous:
No phenotype
Breeding historyWe already described the breeding history in our previous submission of this Prss16 knock-out on C57BL/6 and 129/Sv background (EMMA strain ID EM:01380). For the present submission on CD3epsilon-deficient background, we have crossed homozygous Prss16 knock-out on C57BL/6 background with CD3epsilon delta5 mice (EMMA strain ID EM:00047) provided by Marie Malissen (CIML, France). The resulting double knock-out mice are mandatory for T cells adoptive transfer experiments.
References
  • Thymus-specific serine protease regulates positive selection of a subset of CD4+ thymocytes.;Gommeaux Julien, Grégoire Claude, Nguessan Prudence, Richelme Mireille, Malissen Marie, Guerder Sylvie, Malissen Bernard, Carrier Alice, ;2009;European journal of immunology;39;956-64; 19283781
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredyes
Immunocompromisedyes

Information from EMMA

Archiving centreCNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain
Animals used for archivinghomozygous C57BL/6 males, homozygous C57BL/6 females
Stage of embryos2-cell

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

    • T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta / Orphanet_169160
MGI phenotypes (allele matching)
  • arrested T cell differentiation / MGI
  • abnormal double-negative T cell morphology / MGI
  • abnormal B cell morphology / MGI
  • abnormal regulatory T cell physiology / MGI
  • absent T cells / MGI
  • increased sensitivity to induced morbidity/mortality / MGI
  • absent CD8-positive, alpha-beta T cells / MGI
  • absent CD4-positive, alpha beta T cells / MGI
MGI phenotypes (gene matching)
  • abnormal thymus morphology / MGI
  • small thymus / MGI
  • absent CD8-positive, alpha-beta T cells / MGI
  • thymus hypoplasia / MGI
  • arrested T cell differentiation / MGI
  • seizures / MGI
  • abnormal T cell differentiation / MGI
  • abnormal double-negative T cell morphology / MGI
  • abnormal double-positive T cell morphology / MGI
  • absent CD4-positive, alpha beta T cells / MGI
  • abnormal class switch recombination / MGI
  • abnormal B cell morphology / MGI
  • abnormal regulatory T cell physiology / MGI
  • increased double-negative T cell number / MGI
  • decreased double-positive T cell number / MGI
  • abnormal T cell number / MGI
  • increased T cell apoptosis / MGI
  • abnormal T cell morphology / MGI
  • absent T cells / MGI
  • increased sensitivity to induced morbidity/mortality / MGI
  • increased DN3 thymocyte number / MGI
  • no abnormal phenotype detected / MGI
  • abnormal thymus cortex morphology / MGI
  • immune system phenotype / MGI
  • abnormal professional antigen presenting cell morphology / MGI

Literature references

  • Thymus-specific serine protease regulates positive selection of a subset of CD4+ thymocytes.;Gommeaux Julien, Grégoire Claude, Nguessan Prudence, Richelme Mireille, Malissen Marie, Guerder Sylvie, Malissen Bernard, Carrier Alice, ;2009;European journal of immunology;39;956-64; 19283781

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).